[Brucellosis in children].
It has been studied in a series of 30 children affected of brucellosis, the most important epidemiologic, clinical and biologic characteristics. It has been emphasized the good response to the combined treatment of tetracycline and streptomycin.
D000293:Adolescent; D000367:Age Factors; D002006:Brucellosis / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D013030:Spain; D013307:Streptomycin / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013754:Tetracyclines / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D013754:Tetracyclines; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole; D013307:Streptomycin
Brucelosis infantil.